Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CV Sciences, Inc.CVSI · Entity 8316 | Director | February 05, 2018 | June 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CV Sciences, Inc.
Report date February 05, 2018 · Filed June 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.41 · Expires 2028-02-04 | Direct | 40,000 |
Reported balance
After 2018-02-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-02-05 · Grant · Acquired 40,000 · Balance 40,000 F1: This option is durational-based and vests as follows: the option shares vest in twelve (12) equal monthly installments measured from January 1, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: This option is durational-based and vests as follows: the option shares vest in twelve (12) equal monthly installments measured from January 1, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2018 Filed Jun 6, 2018 17:34 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001683168-18-001602 · sligar_f4.xml · derivative · entry 1 Sligar Gary · CIK 0001680842 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-04 F1 · derivative.exercise_date: This option is durational-based and vests as follows: the option shares vest in twelve (12) equal monthly installments measured from January 1, 2018. Read SEC document |
| July 14, 2017 Filed Mar 28, 2018 12:02 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001683168-18-000773 · sligar_f4.xml · derivative · entry 1 Sligar Gary · CIK 0001680842 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-07-14 F1 · derivative.exercise_date: The option is fully vested on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.